Convalescent Plasma To Limit Coronavirus Associated Complications
The PI and the NYU Grossman School of Medicine (NYUGSOM) Study Team will be responsible for recruiting, randomizing, and following 200 hospitalized patients with COVID-19 from recruitment to 90-day follow-up as per the study protocol. In addition, NYUGSOM will also manage the IND and regulatory reporting for the study. NYUGSOM will additionally create and manage the study database and provide access to the Albert Einstein College of Medicine site. The electronic data capture system will handle all data and safety monitoring across the two institutions.